全球动脉粥状硬化斑块切除术设备市场规模、份额和成长分析：按产品、按应用、按最终用户、按地区 - 产业预测 (2024-2031)

2022年全球动脉粥状硬化斑块切除术设备市场规模约为8.903亿美元，高于2023年的9.6241亿美元，预测期内（2024-2031年）复合年增长率为8.1%，预计2031年将达到17.946亿美元。

全球动脉粥状硬化斑块切除术设备市场预计将大幅成长，主要是由于老年人口增加、不良生活习惯和不健康饮食习惯导致心血管疾病发生率不断上升。随着越来越多的患者寻求有效的治疗方法，这些日益严重的健康问题预计将推动对动脉粥状硬化斑块切除术设备的需求。此外，微创手术的趋势正在获得关注，为动脉粥状硬化斑块切除术设备提供者提供了新的途径，因为医疗专业人员和患者都青睐心血管干预的微创选择。此外，对医学研发的持续投资预计将推动动脉粥状硬化斑块切除术设备的技术进步，并在该领域创造更多商机。然而，它面临着诸如与动脉粥状硬化斑块切除术术和设备相关的高成本、手术期间併发症的潜在风险以及替代治疗方案的可用性等挑战，这可能会阻碍市场的长期扩张。也就是说，不断增长的需求、技术创新以及对微创解决方案不断变化的偏好相结合，可能会使动脉粥状硬化斑块切除术设备供应商在未来几年从这个不断增长的市场中获利。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模估算
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 创新矩阵
• 技术分析
• 监管分析
• 专利分析
• 市场生态系统

动脉粥状硬化斑块切除术设备市场：副产品

• 市场概况
• 定向动脉粥状硬化斑块切除术系统
• 眼眶动脉粥状硬化斑块切除术系统
• 光学消融（雷射）动脉粥状硬化斑块切除术系统
• 旋切动脉粥状硬化斑块切除术系统
• 支援设备
• 其他的

动脉粥状硬化斑块切除术设备市场：依应用分类

• 市场概况
• 周围血管
• 心血管
• 神经血管的

动脉粥状硬化斑块切除术设备市场：依最终用户分类

• 市场概况
• 医院和外科中心
• 门诊治疗中心
• 实验室和学术机构
• 其他的

动脉粥状硬化斑块切除术设备市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Medtronic Plc（Ireland）
• Boston Scientific Corporation（USA）
• Cardiovascular Systems, Inc.（USA）
• Royal Philips（Netherlands）
• Avinger, Inc.（USA）
• Terumo Corporation（Japan）
• AngioDynamics, Inc.（USA）
• Braun Group（Germany）
• Abbott Laboratories（USA）
• B. Braun Melsungen AG（Germany）
• Biotronik SE & Co. KG（Germany）
• Biomerics（USA）
• Philips（Netherlands）
• Cook Medical, Inc.（USA）
• Cardinal Health, Inc.（USA）
• Rex Medical, LP（USA）
• WL Gore & Associates, Inc.（USA）
• Minnetronix, Inc.（USA）
• Merit Medical Systems, Inc.（USA）
• NexStep Medical（USA）

Global Atherectomy Devices Market size was valued at around USD 890.30 million in 2022 and is expected to rise from USD 962.41 million in 2023 to reach a value of USD 1794.60 million by 2031, at a CAGR of 8.1% over the forecast period (2024-2031).

The global market for atherectomy devices is poised for significant growth, driven largely by the escalating incidence of cardiovascular diseases, which are increasingly prevalent due to a growing elderly population, poor lifestyle choices, and unhealthy dietary habits. This rising health concern is expected to bolster the demand for atherectomy devices as more patients seek effective treatment options. Additionally, the trend towards minimally invasive procedures is gaining traction, presenting new avenues for providers of atherectomy devices as healthcare professionals and patients alike favor less invasive options for cardiovascular interventions. Furthermore, ongoing investments in medical research and development are anticipated to propel technological advancements in atherectomy devices, creating even more opportunities in this sector. However, the market faces challenges, including the high costs associated with atherectomy procedures and devices, potential risks of complications during operations, and the availability of alternative treatment options, which may hinder market expansion in the long term. Nonetheless, the confluence of increasing demand, technological innovations, and a shifting preference towards minimally invasive solutions positions atherectomy device providers to capitalize on this growing market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Atherectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Atherectomy Devices Market Segmental Analysis

Global Atherectomy Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Support Devices, and Others. Based on Application, the market is segmented into Peripheral Vascular, Cardiovascular, and Neurovascular. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Atherectomy Devices Market

The global atherectomy devices market is significantly driven by the aging population, which is increasingly at risk for cardiovascular complications like arterial blockages. As older individuals often experience a higher prevalence of such conditions, the demand for effective treatment options is rising. Atherectomy devices, essential for addressing these disorders, are gaining traction due to a growing preference for minimally invasive procedures among geriatric patients. This trend not only enhances patient outcomes but also aligns with the broader shift towards less invasive, safer medical interventions, thereby propelling the market's expansion and adoption in cardiovascular care strategies worldwide.

Restraints in the Global Atherectomy Devices Market

One of the significant market restraints for the global atherectomy devices market is the inherent risk of complications associated with atherectomy procedures. The complexity of these procedures, influenced by numerous variables such as patient anatomy, operator skill, and device selection, presents challenges in ensuring optimal outcomes. The fear of potential complications, including vessel perforation, dissection, or embolization, can deter both healthcare providers and patients from opting for atherectomy as a treatment option. Consequently, the apprehension surrounding these risks may hinder the growth of atherectomy device sales, as medical professionals may seek alternative treatment modalities perceived as less risky.

Market Trends of the Global Atherectomy Devices Market

The Global Atherectomy Devices market is witnessing a notable trend towards the integration of advanced technologies, particularly artificial intelligence (AI) and machine learning (ML). Manufacturers are increasingly focusing on these innovations to enhance the functionality and precision of their devices, ultimately improving patient outcomes in vascular interventions. By harnessing AI and ML, companies can streamline both the development processes and clinical deployment of atherectomy systems, thereby maximizing their operational efficiency and market reach. This technological shift is expected to drive competitive advantage in the marketplace, positioning manufacturers at the forefront of the evolving landscape of cardiovascular treatment solutions.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Innovation Matrix
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Ecosystem of the Market

Global Atherectomy Devices Market, By Product

• Market Overview
• Directional Atherectomy Systems
• Orbital Atherectomy Systems
• Photo-Ablative (Laser) Atherectomy Systems
• Rotational Atherectomy Systems
• Support Devices
• Others

Global Atherectomy Devices Market, By Application

• Market Overview
• Peripheral Vascular Applications
• Cardiovascular Applications
• Neurovascular Applications

Global Atherectomy Devices Market, By End User

• Market Overview
• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Research Laboratories & Academic Institutes
• Others

Atherectomy Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avinger, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rex Medical, L.P. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minnetronix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NexStep Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments